Research Alliance with Bristol Myers Squibb (BMS)
Bristol Myers Squibb (BMS) is a global biopharmaceutical company making advancements in oncology, haematology, immunology and cardiovascular disease. BMS are dedicated to helping patients prevail over serious diseases through a diverse and promising pipeline and new scientific platforms.
About the Oxford-BMS Research Alliance
The Oxford-Bristol Myers Squibb alliance was established in 2015 through our Translational Fellowship Programme, with the aim of stimulating new scientific discovery and translation and to generate a cohort of scientists that can navigate within and across both academic and industry spheres to bridge translational challenges. Oxford's alliance with Bristol Myers Squibb continues to grow year on year, the total of Oxford-Bristol Myers Squibb Fellows is now 34 and many other collaborative projects are currently running.
Alliance Manager
-
Charlotte Bell
Senior Business Partnerships Manager
charlotte.bell@medsci.ox.ac.uk
+44 (0)7711 781932
Fellowship Programme
This prestigious 3-year Fellowship aims to stimulate new scientific discovery and translation and to facilitate skills and people transfer between researchers in academia and industry.
Alliance Activities
- Fellowships
- Visiting Professor
- Sponsored Research Collaborations
- PhD Studentships
- Co-applicants on a grant
Therapeutic areas of interest
- Cardiovascular disease
- Haematology
- Immunology
- Oncology